About Robert Brooks
Form D filings for Alphageneron Pharmaceuticals in 2023 list Robert Brooks as chief executive officer and director.
Robert Brooks first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Brooks in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Brooks works with at each company, as listed on that company's latest Form D.
Alphageneron Pharmaceuticals, Inc. · Form D, Aug 14, 2023
OS
Ola Soderquist
Executive officer
ML
Marc Lippman
Director
BV
Bikash Verma
Director
RC
Robert Clarke
Director
GP
Graham Pockley
Executive officer